US88167AAF84 · Corp · USD

Teva Pharmaceutical Finance Nether 4.10% 2046/10

MID PRICE
77.05
par = 100
YIELD TO MAT.
6.08%
semi-annual
COUPON
4.100%
semi-annual · fixed
MATURITY
2046-10-01
bullet · 20.41y
OUTSTANDING
not disclosed
AS OF
2026-04-30
Fund disclosure

Sign up free to see prices on this bond

Free accounts get 40 bond price views per month — 4× the anonymous quota. Pro is unlimited.

Risk analytics

SEMI-ANNUAL · BULLET · PAR 100
Modified duration
12.57 y
1bp ↑ ≈ -0.126% P&L
Convexity
215.28
higher = more curvature
Years to maturity
20.41 y
YTM source
Ingested
Fund disclosure
Market signals · funds disclosing this bond
SignalCategoryExposureLast moveWeightAs of
iShares Emerging Markets High Yield Bond
iShares
EM High Yield$1.0M▲ $5K0.18%2026-04-30
iShares Emerging Markets Corporate Bond
iShares
EM Corporate$1.0M▲ $5K0.26%2026-04-30
Subscribe to reveal which signals are holding this bond.Subscribe →

Price history

Sherpa Signal

AS OF 2026-04-30

Institutional footprint · signal-level holdings

28/ 100Early footprint
Interpretation. Light institutional footprint, holding
HOLDERS
2
unchanged in 7d
AGGREGATE EXPOSURE
$2.1M
USD across all
TOP CONCENTRATION
50.9%
largest holder
FLOW
▲ $6K
unchanged in 7d

Sherpa Signal is derived from a panel of tracked institutional portfolios. Names of individual holders are not disclosed.

100K PAR NOTIONAL · MARKET VALUE
77,050 USD
PRICE
77.05

RFQ routing · coming soon

Security details

VIA OPENFIGI
Canonical
TEVA 4.1 10/01/46
FIGI
BBG00DDM0L65
CUSIP
88167AAF8
ISIN
US88167AAF84
Type
Corp
Issued
2016-07-21
Face value
100 USD
Ticker
TEVA 4.1 10/01/46
Sec. type
GLOBAL
Seniority
Senior Unsecured

Issuer curve

TEVA · 10 PTS

Yield (%) plotted against years-to-maturity. This bond highlighted in amber.